347 related articles for article (PubMed ID: 23354168)
1. Spatial regulation of VEGF receptor endocytosis in angiogenesis.
Nakayama M; Nakayama A; van Lessen M; Yamamoto H; Hoffmann S; Drexler HC; Itoh N; Hirose T; Breier G; Vestweber D; Cooper JA; Ohno S; Kaibuchi K; Adams RH
Nat Cell Biol; 2013 Mar; 15(3):249-60. PubMed ID: 23354168
[TBL] [Abstract][Full Text] [Related]
2. Endocytosis regulates VEGF signalling during angiogenesis.
Gaengel K; Betsholtz C
Nat Cell Biol; 2013 Mar; 15(3):233-5. PubMed ID: 23449144
[TBL] [Abstract][Full Text] [Related]
3. Regulation of signaling interactions and receptor endocytosis in growing blood vessels.
Pitulescu ME; Adams RH
Cell Adh Migr; 2014; 8(4):366-77. PubMed ID: 25482636
[TBL] [Abstract][Full Text] [Related]
4. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
Wang Y; Nakayama M; Pitulescu ME; Schmidt TS; Bochenek ML; Sakakibara A; Adams S; Davy A; Deutsch U; Lüthi U; Barberis A; Benjamin LE; Mäkinen T; Nobes CD; Adams RH
Nature; 2010 May; 465(7297):483-6. PubMed ID: 20445537
[TBL] [Abstract][Full Text] [Related]
5. Eph-B2/ephrin-B2 interaction plays a major role in the adhesion and proliferation of Waldenstrom's macroglobulinemia.
Azab F; Azab AK; Maiso P; Calimeri T; Flores L; Liu Y; Quang P; Roccaro AM; Sacco A; Ngo HT; Zhang Y; Morgan BL; Carrasco RD; Ghobrial IM
Clin Cancer Res; 2012 Jan; 18(1):91-104. PubMed ID: 22010211
[TBL] [Abstract][Full Text] [Related]
6. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis.
Sawamiphak S; Seidel S; Essmann CL; Wilkinson GA; Pitulescu ME; Acker T; Acker-Palmer A
Nature; 2010 May; 465(7297):487-91. PubMed ID: 20445540
[TBL] [Abstract][Full Text] [Related]
7. Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway.
Lee HK; Chauhan SK; Kay E; Dana R
Blood; 2011 May; 117(21):5762-71. PubMed ID: 21460247
[TBL] [Abstract][Full Text] [Related]
8. Regulation of vascular endothelial growth factor receptor function in angiogenesis by numb and numb-like.
van Lessen M; Nakayama M; Kato K; Kim JM; Kaibuchi K; Adams RH
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1815-25. PubMed ID: 26069237
[TBL] [Abstract][Full Text] [Related]
9. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations.
You C; Sandalcioglu IE; Dammann P; Felbor U; Sure U; Zhu Y
J Cell Mol Med; 2013 Mar; 17(3):407-18. PubMed ID: 23388056
[TBL] [Abstract][Full Text] [Related]
10. Ephrin-B2 controls PDGFRβ internalization and signaling.
Nakayama A; Nakayama M; Turner CJ; Höing S; Lepore JJ; Adams RH
Genes Dev; 2013 Dec; 27(23):2576-89. PubMed ID: 24298057
[TBL] [Abstract][Full Text] [Related]
11. Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling.
Qin J; Chen X; Yu-Lee LY; Tsai MJ; Tsai SY
Cancer Res; 2010 Nov; 70(21):8812-21. PubMed ID: 20978203
[TBL] [Abstract][Full Text] [Related]
12. Syntenin promotes VEGF-induced VEGFR2 endocytosis and angiogenesis by increasing ephrin-B2 function in endothelial cells.
Tae N; Lee S; Kim O; Park J; Na S; Lee JH
Oncotarget; 2017 Jun; 8(24):38886-38901. PubMed ID: 28418925
[TBL] [Abstract][Full Text] [Related]
13. BAZF, a novel component of cullin3-based E3 ligase complex, mediates VEGFR and Notch cross-signaling in angiogenesis.
Ohnuki H; Inoue H; Takemori N; Nakayama H; Sakaue T; Fukuda S; Miwa D; Nishiwaki E; Hatano M; Tokuhisa T; Endo Y; Nose M; Higashiyama S
Blood; 2012 Mar; 119(11):2688-98. PubMed ID: 22279058
[TBL] [Abstract][Full Text] [Related]
14. Anosmin-1 activates vascular endothelial growth factor receptor and its related signaling pathway for olfactory bulb angiogenesis.
Matsushima S; Shimizu A; Kondo M; Asano H; Ueno N; Nakayama H; Sato N; Komeno M; Ogita H; Kurokawa-Seo M
Sci Rep; 2020 Jan; 10(1):188. PubMed ID: 31932617
[TBL] [Abstract][Full Text] [Related]
15. Sonic hedgehog induces angiogenesis via Rho kinase-dependent signaling in endothelial cells.
Renault MA; Roncalli J; Tongers J; Thorne T; Klyachko E; Misener S; Volpert OV; Mehta S; Burg A; Luedemann C; Qin G; Kishore R; Losordo DW
J Mol Cell Cardiol; 2010 Sep; 49(3):490-8. PubMed ID: 20478312
[TBL] [Abstract][Full Text] [Related]
16. Opposite angiogenic outcome of curcumin against ischemia and Lewis lung cancer models: in silico, in vitro and in vivo studies.
Fan S; Xu Y; Li X; Tie L; Pan Y; Li X
Biochim Biophys Acta; 2014 Sep; 1842(9):1742-54. PubMed ID: 24970744
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma.
Nagaraj SR; Shilpa P; Rachaiah K; Salimath BP
Mol Carcinog; 2015 May; 54(5):333-50. PubMed ID: 24265228
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
[TBL] [Abstract][Full Text] [Related]
19. Type II transforming growth factor-beta receptor recycling is dependent upon the clathrin adaptor protein Dab2.
Penheiter SG; Singh RD; Repellin CE; Wilkes MC; Edens M; Howe PH; Pagano RE; Leof EB
Mol Biol Cell; 2010 Nov; 21(22):4009-19. PubMed ID: 20881059
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling.
Xu Z; Yu Y; Duh EJ
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4059-66. PubMed ID: 16936124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
